# ClinicalTrials.gov record NCT02860923

> PeptideScanner retained ClinicalTrials.gov record NCT02860923 at 2026-07-30T16:19:36.924Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct02860923-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02860923-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02860923-exenatide-v1.json
- Content SHA-256: `f287eb87f0ab15e83e69eb75b739d9686d9a8ed733ae1abd125b74bbf1e8b6f1`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02860923 ([`ctg-observation-nct02860923-2026-05-22-36d96a383758`](#source-ctg-observation-nct02860923-2026-05-22-36d96a383758))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02860923 at 2026-07-30T16:19:36.924Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02860923-2026-05-22-36d96a383758`](#source-ctg-observation-nct02860923-2026-05-22-36d96a383758))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02860923 at 2026-07-30T16:19:36.924Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02860923-2026-05-22-36d96a383758`](#source-ctg-observation-nct02860923-2026-05-22-36d96a383758))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02860923-2026-05-22-36d96a383758`](#source-ctg-observation-nct02860923-2026-05-22-36d96a383758))

## Sources

<a id="source-ctg-observation-nct02860923-2026-05-22-36d96a383758"></a>
- **ClinicalTrials.gov record NCT02860923 · retained source version 2026-05-22:36d96a3837587e56a762a744e3c3a5cd1ad36b439a9e273a0797e43a25d83aff** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02860923) (`ctg-observation-nct02860923-2026-05-22-36d96a383758`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02860923." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02860923-exenatide-v1.json SHA-256: f287eb87f0ab15e83e69eb75b739d9686d9a8ed733ae1abd125b74bbf1e8b6f1.